Loading…
Advanced Biomed Inc. is projected to rise to $7.19 by 2027, a +39% move from its current price of $5.16. ADVB is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.90 | $5.15 | $5.43 | -0.11% |
| Jul 14 | $4.79 | $5.15 | $5.54 | -0.22% |
| Jul 15 | $4.70 | $5.14 | $5.62 | -0.34% |
| Jul 16 | $4.63 | $5.14 | $5.69 | -0.45% |
| Jul 17 | $4.57 | $5.13 | $5.76 | -0.56% |
| Jul 18 | $4.52 | $5.13 | $5.81 | -0.67% |
| Jul 19 | $4.47 | $5.12 | $5.87 | -0.78% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.47 | $5.12 | $5.87 | -0.78% |
| Week 2 | $4.19 | $5.08 | $6.16 | -1.56% |
| Week 3 | $3.98 | $5.04 | $6.38 | -2.34% |
| Week 4 | $3.81 | $5.00 | $6.56 | -3.10% |
| Week 5 | $3.66 | $4.96 | $6.73 | -3.86% |
| Week 6 | $3.53 | $4.92 | $6.87 | -4.62% |
| Week 7 | $3.41 | $4.88 | $7.00 | -5.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Advanced Biomed Inc. is an investment holding company that engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product.
The company also offers microfluidic biochips, such as A+Pre, AC-1000 CTC enrichment, and A+CellScan chips to provide assay products and services to cancer patients. In addition, its immunochromogenic kits include A+CTCE kit to identify epithelial circulating tumor cells and determined by the immunochromogenicity of EpCAM, CK (pan), CD45, and CD14 antibodies; A+CTCM kit to identify mesenchymal circulating tumor cells based on the immunochromogenicity of Vimentin, CD45, and CD14 antibodies; A+EMT to identify epithelial-to-mesenchymal circulating tumor cells determined by the immunochromogenicity of cell-surface Vimentin, and CD45 and CD14 antibodies; and A+CM to identify tumor-associated macrophages based on the immunochromogenicity of PD-L1, CD45, and CD14 antibodies. Further, the company is developing A+LCGuard for early screening of lung cancer.
Additionally, it establishes and operates medical clinics in the People's Republic of China. The company was founded in 2014 and is headquartered in New York, New York.
Advanced Biomed Inc. (ADVB) is currently priced at $5.35 with a market cap of $8.84M, and it ranks 5164 by market cap. The current price position is complemented by a near-term technical backdrop, with a bullish tone suggested by the daily indicators that surround the price.
The forecast indicates bullish sentiment in many future years, with average prices rising through the late 2020s and into the 2030s and beyond, and ROIs climbing to substantial levels in the 2040s and 2050s.
A major floor 39.9% below — a decisive break under it would weaken the trend.
The nearest floor, 28.1% below — buyers have tended to step in here.
The nearest ceiling, 3.7% above — a clean break opens room to run.
A major ceiling 39.5% above — clearing it would confirm fresh momentum.
Key ADVB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ADVB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.19 | Sell | $5.15 | Buy |
| MA 10 | $4.96 | Buy | $5.04 | Buy |
| MA 20 | $4.84 | Buy | $4.89 | Buy |
| MA 50 | $4.82 | Buy | $4.86 | Buy |
| MA 100 | $4.85 | Buy | $5.36 | Sell |
| MA 200 | $6.28 | Sell | $9.33 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.40 | Neutral |
| Stoch RSI (14) | 61.16 | Neutral |
| CCI (20) | 73.29 | Neutral |
| Williams %R (14) | -22.09 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 0.88 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 77.91 | Neutral |
| TRIX (15) | 0.30 | Buy |
| Awesome (5,34) | 0.63 | Buy |
| Ultimate (7,14,28) | 60.46 | Neutral |
| Momentum (10) | 0.17 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 5.32 | Sell |
| ADX (14) | 11.45 | Neutral |
| ATR (14) | 0.23 | Info |
The 30-day technical picture shows a bullish tilt, with RSI14 at 60 and key moving averages nearby. The SMA50 is at $4.84 and the SMA200 is at $6.35, framing near-term support and resistance levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.71 | $5.16 | $6.91 | 0% | Neutral | |
| $5.18 | $7.19 | $10.80 | +39% | Bullish | |
| $5.60 | $8.29 | $13.30 | +61% | Bullish | |
| $4.42 | $6.92 | $11.66 | +34% | Bullish | |
| $4.23 | $6.94 | $12.20 | +35% | Bullish | |
| $3.99 | $6.87 | $12.51 | +33% | Bullish | |
| $3.74 | $6.74 | $12.66 | +31% | Bullish | |
| $4.74 | $8.90 | $17.19 | +72% | Bullish | |
| $5.09 | $9.97 | $19.76 | +93% | Bullish | |
| $5.04 | $10.28 | $20.85 | +99% | Bullish | |
| $6.35 | $14.11 | $31.53 | +174% | Bullish | |
| $7.11 | $15.80 | $36.35 | +206% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.71 | $5.16 | $6.50 | +0.00% |
| August 2026 | $4.22 | $5.12 | $6.48 | -0.71% |
| September 2026 | $3.78 | $4.66 | $6.02 | -9.11% |
| October 2026 | $3.81 | $4.75 | $6.25 | +2.02% |
| November 2026 | $4.07 | $5.13 | $6.85 | +7.93% |
| December 2026 | $4.01 | $5.10 | $6.91 | -0.51% |
Click any year to see its month-by-month ADVB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Advanced Biomed Inc.'s 2026 outlook centres on $5.16, within a $3.71 to $6.91 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ADVB could reach as high as $10.80, with a base case around $7.19 and support toward $5.18 — roughly +39% from $5.16. Buyers look set to stay in control over this stretch.
Expect ADVB to range from $5.60 to $13.30 through 2028. The $8.29 average target implies a +61% move from current prices. That is up +15% on the projected 2027 average. Momentum favours further upside here.
The ADVB price prediction for 2029 points to an average of $6.92 (low $4.42, high $11.66) — a potential gain of +34% on today's $5.16. Buyers look set to stay in control over this stretch.
In 2030, ADVB is projected to trade between $4.23 and $12.20, averaging $6.94 — a potential gain of +35% from today's $5.16. That is up 0% on the projected 2029 average. Momentum favours further upside here.
Advanced Biomed Inc.'s 2031 outlook centres on $6.87, within a $3.99 to $12.51 range. That is -1% versus the projected 2030 average. That marks a +33% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ADVB could reach as high as $12.66, with a base case around $6.74 and support toward $3.74 — roughly +31% from $5.16. Momentum favours further upside here.
Expect ADVB to range from $4.74 to $17.19 through 2033. The $8.90 average target implies a +72% move from current prices. That is up +32% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ADVB price prediction for 2034 points to an average of $9.97 (low $5.09, high $19.76) — a potential gain of +93% on today's $5.16. Momentum favours further upside here.
In 2035, ADVB is projected to trade between $5.04 and $20.85, averaging $10.28 — a potential gain of +99% from today's $5.16. That is up +3% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Advanced Biomed Inc.'s 2040 outlook centres on $14.11, within a $6.35 to $31.53 range. That is up +37% on the projected 2035 average. That marks a +174% change versus current levels. Momentum favours further upside here.
By 2050, ADVB could reach as high as $36.35, with a base case around $15.80 and support toward $7.11 — roughly +206% from $5.16. Buyers look set to stay in control over this stretch.
Investing $1,000 in ADVB today (≈ 193.79845 ADVB) could be worth
$3,062.96
+$2,062.96 (+206%) by 2050 · US Dollar
Based on the average projected ADVB price of $15.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ADVBwould be worth at today's price.
$1,000 invested in ADVB on Jul 10, 2025 (≈ 63.694268 ADVB) would be worth
$328.66
-$671.34 (-67.1%) today · 0.33× · US Dollar
Based on a ADVB entry price of $15.7 vs. today's $5.16.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.99 | $1,034.07 | +3.4% |
| 1 month ago | $3.89 | $1,325.46 | +32.5% |
| 3 months ago | $6.6 | $781.82 | -21.8% |
| 6 months ago | $7.16 | $720.67 | -27.9% |
| 1 year ago | $15.7 | $328.66 | -67.1% |
| All time (1.3y) ago | $73 | $70.68 | -92.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ADVB forecast.
Our base-case forecast reaches $10.00 around 2035.
Implied market cap at $10.00: $16.52M
Looking across the multi-year forecast, the asset exhibits a rising path in its average price through the late 2020s and into the 2030s. The 2026 forecast sits at an average of $5.35, with a minimum of $3.71 and a maximum of $7.29. For 2027, the average climbs to $7.71 (min $5.49, max $11.71) with ROI 44.1 and bullish sentiment, followed by 2028 at an average of $8.81 (min $5.87, max $14.32) with ROI 64.7 and bullish sentiment.
The 2030 forecast shows an average of $7.38 (min $4.40, max $13.17) with ROI 37.9 and bullish sentiment, and the path continues to rise in later years, including 2033 (avg $9.80, max $19.28, ROI 83.2) and 2034 (avg $10.85, max $21.92, ROI 102.9). By 2040 the average is projected at $15.45 with ROI 188.8, and by 2050 the average reaches $17.20 with ROI 221.5, both maintaining bullish sentiment. These figures illustrate meaningful upside potential across the horizon, tempered by the inherent uncertainty of price forecasts.
Tap a question to reveal the answer.
2030 Avg $7.38; Min $4.40; Max $13.17; ROI 37.9; Sentiment BULLISH.
The forecast shows bullish sentiment in most years after 2026, with rising Avg prices and strong ROIs (e.g., 2027 Avg $7.71, ROI 44.1; 2040 Avg $15.45, ROI 188.8; 2050 Avg $17.20, ROI 221.5). These are estimates, not guarantees.
Yes. The 2034 max is $21.92, which exceeds $20, indicating a potential crossing of that level by that year.
Current price is $5.35 and market cap is $8.84M.
The 30-day range is from $3.76 to $7.61.
Advanced Biomed Inc. Community Discussion
0Share your Advanced Biomed Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.